Valuation BioHarvest Sciences Inc. Canadian Securities Exchange
Stocks
BHSC
CA13767B1013
Pharmaceuticals
|
Delayed
Canadian Securities Exchange
07:54:58 05/10/2021 pm IST
|
5-day change | 1st Jan Change | ||
| 0.3500 CAD | +6.06% |
|
-2.94% | +46.67% |
| 15/09 | BioHarvest Sciences Inc. Launches Single-Dose VINIA Daily Chews | CI |
| 11/08 | BioHarvest Sciences Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Company Valuation: BioHarvest Sciences Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 75.75 | 107.1 | 117.6 | 36.95 | - | - |
| Change | - | 41.36% | 9.8% | -68.57% | - | - |
| Enterprise Value (EV) | 75.75 | 107.1 | 117.6 | 36.95 | 36.95 | 36.95 |
| Change | - | 41.36% | 9.8% | -68.57% | 0% | 0% |
| P/E | -5.28x | -7.73x | -8.65x | -3.09x | -4.87x | 12.5x |
| PBR | - | - | - | - | - | - |
| PEG | - | 0.3x | 0.3x | 0.3x | 0.1x | -0x |
| Capitalization / Revenue | - | 4.25x | 3.41x | 0.99x | 0.75x | 0.52x |
| EV / Revenue | - | 0x | 0x | 0.99x | 0.75x | 0.52x |
| EV / EBITDA | - | -0x | -0x | -4.85x | -10.1x | 7.72x |
| EV / EBIT | - | -0x | -0x | -4.12x | -7.59x | 6.65x |
| EV / FCF | - | -0x | -0x | -3.13x | -2.81x | 8.63x |
| FCF Yield | - | -8.89% | -8.15% | -31.9% | -35.6% | 11.6% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.05 | -0.8 | -0.6 | -0.5275 | -0.335 | 0.13 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 25.19 | 34.51 | 37.42 | 49.59 | 71.53 |
| EBITDA 1 | - | -5.738 | -3.951 | -7.618 | -3.641 | 4.786 |
| EBIT 1 | - | -6.989 | -5.575 | -8.977 | -4.87 | 5.555 |
| Net income 1 | -12.56 | -12.91 | -11.14 | -12.02 | -7.648 | 3.409 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 5.539 | 6.180 | 5.190 | 1.630 | 1.630 | 1.630 |
| Nbr of stocks (in thousands) | 13,677 | 17,328 | 22,654 | 22,668 | - | - |
| Announcement Date | 30/04/24 | 31/03/25 | 31/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.46x | 2.03x | 13.79x | 5.47% | 1.36TCr | |
| 24.93x | 1.34x | 8.71x | 2.26% | 475.18Cr | |
| 14.95x | 3.01x | 9.23x | 6.62% | 431Cr | |
| 16.89x | - | - | 1.38% | 378.92Cr | |
| 25.75x | - | - | - | 343.56Cr | |
| 15.51x | 2.22x | 9.31x | 2.8% | 308.96Cr | |
| Average | 19.08x | 2.15x | 10.26x | 3.7% | 549.46Cr | |
| Weighted average by Cap. | 18.41x | 2.09x | 11.55x | 4.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BHST Stock
- BHSC Stock
- Valuation BioHarvest Sciences Inc.
Select your edition
All financial news and data tailored to specific country editions
